Back to Search
DARREN CHARLES HOLLENBAUGH MD, FACC
MD, FACC
Cardiovascular Disease Physician
NPI: 1861425571IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
MD-28796(WA)
Education
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Class of 1989
Research & Publications (20)
Use of monoclonal antibodies for expression cloning.
PMID 18265331·Curr Protoc Mol Biol·2003
7-preclinical
Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation.
PMID 19592649·J Immunol·2009
7-preclinical
Discovery of a cytokine and its receptor by functional screening of the extracellular proteome.
PMID 18467591·Science·2008
7-preclinical
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold.
PMID 15686933·Bioorg Med Chem Lett·2005
8-other
Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival.
PMID 15611281·J Immunol·2005
7-preclinical
Quinolone-based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analogues.
PMID 12565969·Bioorg Med Chem Lett·2003
8-other
Novel inhibitors of IMPDH: a highly potent and selective quinolone-based series.
PMID 12565968·Bioorg Med Chem Lett·2003
8-other
Novel indole-based inhibitors of IMPDH: introduction of hydrogen bond acceptors at indole C-3.
PMID 12657262·Bioorg Med Chem Lett·2003
8-other
Identification of novel and potent isoquinoline aminooxazole-based IMPDH inhibitors.
PMID 12657279·Bioorg Med Chem Lett·2003
8-other
Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-Methoxy-4-(5-oxazolyl)phenyl moiety.
PMID 12781195·Bioorg Med Chem Lett·2003
7-preclinical
3-cyanoindole-based inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships.
PMID 14505670·Bioorg Med Chem Lett·2003
8-other
Novel guanidine-based inhibitors of inosine monophosphate dehydrogenase.
PMID 12270177·Bioorg Med Chem Lett·2002
8-other
Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
PMID 12394833·Transplantation·2002
7-preclinical
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.
PMID 12014950·J Med Chem·2002
7-preclinical
Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates.
PMID 11812731·Diabetes·2002
4-observational
Novel amide-based inhibitors of inosine 5'-monophosphate dehydrogenase.
PMID 12270168·Bioorg Med Chem Lett·2002
8-other
Rapid synthesis of triazine inhibitors of inosine monophosphate dehydrogenase.
PMID 12127522·Bioorg Med Chem Lett·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 62 W 7th Ave Ste 232
Spokane, WA 99204 - Phone
- (509) 455-8820
Quick Facts
- NPI
- 1861425571
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile